Danaher Corporation $DHR Shares Purchased by Groupama Asset Managment

Groupama Asset Managment boosted its holdings in Danaher Corporation (NYSE:DHR) by 22.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 54,461 shares of the conglomerate’s stock after buying an additional 10,027 shares during the quarter. Groupama Asset Managment’s holdings in Danaher were worth $12,374,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of DHR. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at approximately $26,000. WFA of San Diego LLC purchased a new position in Danaher in the second quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher during the third quarter worth approximately $27,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in Danaher during the fourth quarter worth approximately $27,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of DHR opened at $177.74 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a market cap of $125.80 billion, a PE ratio of 34.38, a price-to-earnings-growth ratio of 2.27 and a beta of 0.81. The company’s 50 day simple moving average is $179.99 and its 200-day simple moving average is $203.25. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHR) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same period in the previous year, the company posted $1.88 EPS. The company’s quarterly revenue was up 3.7% on a year-over-year basis. As a group, equities analysts predict that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s payout ratio is currently 30.95%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on DHR shares. Argus lowered their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. The Goldman Sachs Group cut their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. UBS Group reduced their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Robert W. Baird decreased their price objective on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. Finally, Guggenheim dropped their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.